SEO URLwww.firestrike.ai/deals/sandoz-strides-acquisition-2026-4
acquisitionAnnounced · Mar 18, 2026PharmaceuticalsSource · Community DiscussionsArticle · Factual
Strides acquires Sandoz
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$12M
Target
Sandoz
SIX: SDZ · Basel, Basel-City
Acquirer
Strides
Full Acquisition
Status
Pending
Strides agreed to acquire Sandoz. Reported deal value: $12M. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.
This page summarizes publicly available information about the transaction as of 2026-03-18. Figures and status may change as filings and press coverage update.
Strides Pharma Science Limited announced that its step-down subsidiary, Strides Pharma International AG , has entered into definitive agreements with Sandoz AG and its group entities for the acquisition and in-licensing of a portfolio of branded generic products across Sub-Saharan Africa
Deal timeline
Announced
Mar 18, 2026 · ehealth.eletsonline.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $12M. Figures and status may change as sources update.
Sources: ehealth.eletsonline.com · Primary article · FireStrike proprietary index